Wings Biotech Limited - Due diligence report

A 360° intelligence report on Wings Biotech: trust score, financial health, credit view, compliance, directors, growth and distress signals …

2011-12-05 Delhi, Delhi Amalgamated Unlisted Active Compliant
Share
WB Wings Biotech Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Wings Biotech — 360° Intelligence Report

Generated from MCA filings & public records
37/100
Trust Score
Caution Indicated

Wings Biotech is assessed as Caution Indicated with a Trust Score of 37/100. Wings Biotech is a public limited indian non-government company incorporated in 2011, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.

Report generated on 18 Jul 2026 from the latest processed filings. Wings Biotech Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Weak
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreCaution Indicated
37/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
23/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
5/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
5/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 23/100 Caution Indicated
  • Company status is "Amalgamated" - not Active.
  • Last balance sheet is for Mar 2019 - filings overdue.
  • Litigation present in 1 court forum(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
DEVENDER PAL ROHEWAL 01234567 Director 01/04/2018 6 yrs Approved
ANIL ARORA 01234567 Director 01/04/2018 6 yrs Approved
RAJINDER PRASAD ARORA 01234567 Director 01/04/2018 6 yrs Approved
RAKESH ARORA 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2019)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2019 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
0 allotment(s) · 6 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 40 · Distress 5
Growth signals & trust indicators
Operating for 14+ years.
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Negative net worth.
Statutory filings appear overdue.
Adverse company status: Amalgamated.
Compliance score is weak (23/100).
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence22/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 5 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment28/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view27/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 13 events
30 Sep 2019
Last AGM held
Annual general meeting
31 Mar 2019
Latest balance sheet
Filed with ROC
31 Mar 2018
Share transfer (FY 2018)
980.00000000 shares to KAMAL KISHAN ARORA
Share transfer (FY 2018)
6750.00000000 shares to KAMAL KRISHAN ARORA
Share transfer (FY 2018)
2510.00000000 shares to KAMAL KRISHAN ARORA
Share transfer (FY 2018)
2510.00000000 shares to USHA ARORA
Share transfer (FY 2018)
5750.00000000 shares to ANIL ARORA
31 Mar 2017
Share transfer (FY 2017)
2500.00000000 shares to ARORA
23 Jan 2012
Director appointed
DEVENDER PAL ROHEWAL (Director)
05 Dec 2011
Incorporated
Registered with Roc Delhi
Director appointed
ANIL ARORA (Director)
Director appointed
RAJINDER PRASAD ARORA (Director)
Director appointed
RAKESH ARORA (Director)
10

Key Observations

Auto-generated from the data above
Revenue declined 38% over the last 4 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
4 active director(s) / partner(s); board looks stable and experienced.
Promoters hold a dominant controlling stake as per the FY 2019 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Dj Alloys Private Limited U27100GJ2015PTC081706 Ahmadabad City, Gujarat, India
Akal America Wireless Accessories Private Limited U64200MH2007PTC176818 Nagpur, Maharashtra, India
Mobiza Solutions Private Limited U74999TN2017PTC118635 Chennai, Tamil Nadu, India
Store Indya Private Limited U74999MH2013PTC244038 Mumbai, Maharashtra, India
Oewpl U29300PN2011PTC139065 Chinchwad, Maharashtra, India
Nsme U24233KA2012PTC064272 Bangalore, Karnataka, India
Kik Digital Led India Private Limited U51909WB2015PTC208939 Kolkata, West Bengal, India
Shri Shamlaji Sales Private Limited U52609TG2016PTC109598 Secunderabad, Telangana, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Wings Biotech before audits and certifications: compliance score 23/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Wings Biotech: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 40/100, margin trends, ownership structure and peer set for Wings Biotech - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 37/100, distress signals and MSME payment-delay disclosures - know whether Wings Biotech pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Wings Biotech - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Wings Biotech an active company?

Wings Biotech has MCA status “Amalgamated” with a compliance score of 23/100 (Caution Indicated).

Is Wings Biotech financially healthy?

Wings Biotech has a Financial Health Score of 5/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Wings Biotech?

Its overall Trust Score is 37/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Wings Biotech?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 4 active director(s) are on record.

Does Wings Biotech have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Wings Biotech up to date with its ROC filings?

Last balance sheet is for Mar 2019 - filings overdue. Overall compliance score: 23/100 (Caution Indicated).

Is it risky to lend to Wings Biotech?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.